LIPOCINE INC. Financing Cash Flow
LIPOCINE INC. (LPCN) reported Financing Cash Flow of $13.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- LIPOCINE INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.51M.
- LIPOCINE INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $11.97M.
- LIPOCINE INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.65M.
- LIPOCINE INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $141.33K.
- LIPOCINE INC. net cash provided by (used in) financing activities for fiscal 2025 was $2.87M, a 1270.76% increase from fiscal 2024.
- LIPOCINE INC. net cash provided by (used in) financing activities for fiscal 2024 was $209.34K, a 48.26% decline from fiscal 2023.
- LIPOCINE INC. net cash provided by (used in) financing activities for fiscal 2023 was $404.57K.
- LIPOCINE INC. net cash provided by (used in) financing activities for fiscal 2022 was -$2.13M, a 107.90% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed | Net Cash Provided by (Used in) Financing Activities 15 month | Net Cash Provided by (Used in) Financing Activities 18 month | Net Cash Provided by (Used in) Financing Activities 21 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $13.48M 10-Q · filed 2026-08-04 | $16.13M derived: sum of 3 quarters · filed 2026-08-04 | $16.27M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2026-03-31 | $11.97M 10-Q · filed 2026-05-07 | $14.62M derived: sum of 2 quarters · filed 2026-05-07 | $14.76M derived: sum of 3 quarters · filed 2026-05-07 | ||||||
| 2025-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.79M derived: sum of 2 quarters · filed 2026-03-10 | $2.87M 10-K · filed 2026-03-10 | ||||||
| 2025-09-30 | $141.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $216.95K 10-Q · filed 2025-11-06 | |||||||
| 2025-06-30 | $75.62K 10-Q · filed 2026-08-04 | ||||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $217.44K derived: sum of 3 quarters · filed 2026-03-10 | $209.34K 10-K · filed 2026-03-10 | |||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $217.44K derived: sum of 2 quarters · filed 2025-11-06 | $209.34K 10-Q · filed 2025-11-06 | $204.04K derived: sum of 4 quarters · filed 2025-11-06 | |||||
| 2024-06-30 | $217.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $209.34K 10-Q · filed 2025-08-05 | $204.04K derived: sum of 3 quarters · filed 2025-08-05 | $625.12K derived: sum of 4 quarters · filed 2025-08-05 | |||||
| 2024-03-31 | -$8.10K 10-Q · filed 2025-05-08 | -$13.40K derived: sum of 2 quarters · filed 2025-05-08 | $407.68K derived: sum of 3 quarters · filed 2025-05-08 | $402.48K derived: sum of 4 quarters · filed 2025-05-08 | |||||
| 2023-12-31 | -$5.30K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $415.78K derived: sum of 2 quarters · filed 2025-03-13 | $410.58K derived: sum of 3 quarters · filed 2025-03-13 | $404.57K 10-K · filed 2025-03-13 | |||||
| 2023-09-30 | $421.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $415.88K derived: sum of 2 quarters · filed 2024-11-07 | $409.87K 10-Q · filed 2024-11-07 | $403.97K derived: sum of 4 quarters · filed 2024-11-07 | |||||
| 2023-06-30 | -$5.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$11.22K 10-Q · filed 2024-08-08 | -$17.12K derived: sum of 3 quarters · filed 2024-08-08 | -$17.07K derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | -$6.02K 10-Q · filed 2024-05-09 | -$11.92K derived: sum of 2 quarters · filed 2024-05-09 | -$11.87K derived: sum of 3 quarters · filed 2024-05-09 | -$1.51M derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | -$5.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$5.86K derived: sum of 2 quarters · filed 2024-03-07 | -$1.50M derived: sum of 3 quarters · filed 2024-03-07 | -$2.13M 10-K · filed 2024-03-07 | |||||
| 2022-09-30 | $44.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.49M derived: sum of 2 quarters · filed 2023-11-08 | -$2.12M 10-Q · filed 2023-11-08 | -$2.96M derived: sum of 4 quarters · filed 2023-11-08 | |||||
| 2022-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.12M 10-Q · filed 2023-08-10 | -$2.96M derived: sum of 3 quarters · filed 2023-08-10 | -$3.80M derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | -$627.35K 10-Q · filed 2023-05-11 | -$1.47M derived: sum of 2 quarters · filed 2023-05-11 | -$2.30M derived: sum of 3 quarters · filed 2023-05-11 | -$3.14M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$838.46K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | -$1.68M derived: sum of 2 quarters · filed 2023-03-10 | -$2.52M derived: sum of 3 quarters · filed 2023-03-10 | $26.92M 10-K · filed 2023-03-10 | |||||
| 2021-09-30 | -$838.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.68M derived: sum of 2 quarters · filed 2022-11-09 | $27.76M 10-Q · filed 2022-11-09 | $32.32M derived: sum of 4 quarters · filed 2022-11-09 | |||||
| 2021-06-30 | -$838.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $28.60M 10-Q · filed 2022-08-08 | $33.16M derived: sum of 3 quarters · filed 2022-08-08 | $37.82M derived: sum of 4 quarters · filed 2022-08-08 | |||||
| 2021-03-31 | $29.44M 10-Q · filed 2022-05-09 | $34.00M derived: sum of 2 quarters · filed 2022-05-09 | $38.66M derived: sum of 3 quarters · filed 2022-05-09 | $45.46M derived: sum of 4 quarters · filed 2022-05-09 | |||||
| 2020-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $9.22M derived: sum of 2 quarters · filed 2022-03-09 | $16.02M derived: sum of 3 quarters · filed 2022-03-09 | $20.90M 10-K · filed 2022-03-09 | |||||
| 2020-09-30 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $11.46M derived: sum of 2 quarters · filed 2021-11-10 | $16.34M 10-Q · filed 2021-11-10 | $22.16M derived: sum of 4 quarters · filed 2021-11-10 | |||||
| 2020-06-30 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $11.68M 10-Q · filed 2021-08-05 | $17.50M derived: sum of 3 quarters · filed 2021-08-05 | $17.32M derived: sum of 4 quarters · filed 2021-08-05 | |||||
| 2020-03-31 | $4.88M 10-Q · filed 2021-05-06 | $10.69M derived: sum of 2 quarters · filed 2021-05-06 | $10.52M derived: sum of 3 quarters · filed 2021-05-06 | $9.97M derived: sum of 4 quarters · filed 2021-05-06 | |||||
| 2019-12-31 | $5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $5.64M derived: sum of 2 quarters · filed 2021-03-11 | $5.09M derived: sum of 3 quarters · filed 2021-03-11 | $10.32M 10-K · filed 2021-03-11 | |||||
| 2019-09-30 | -$173.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$725.56K derived: sum of 2 quarters · filed 2020-11-10 | $4.50M 10-Q · filed 2020-11-10 | $5.07M derived: sum of 4 quarters · filed 2020-11-10 | |||||
| 2019-06-30 | -$552.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.68M 10-Q · filed 2020-08-06 | $5.24M derived: sum of 3 quarters · filed 2020-08-06 | $5.33M derived: sum of 4 quarters · filed 2020-08-06 | |||||
| 2019-03-31 | $5.23M 10-Q · filed 2020-05-07 | $5.79M derived: sum of 2 quarters · filed 2020-05-07 | $5.88M derived: sum of 3 quarters · filed 2020-05-07 | $5.88M derived: sum of 4 quarters · filed 2020-05-07 | |||||
| 2018-12-31 | $561.57K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $652.33K derived: sum of 2 quarters · filed 2020-03-13 | $652.33K derived: sum of 3 quarters · filed 2020-03-13 | $10.65M 10-K · filed 2020-03-13 | |||||
| 2018-09-30 | $90.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $90.76K derived: sum of 2 quarters · filed 2019-11-12 | $10.09M 10-Q · filed 2019-11-12 | $10.14M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $10.00M 10-Q · filed 2019-08-07 | $10.05M derived: sum of 3 quarters · filed 2019-08-07 | $12.43M derived: sum of 4 quarters · filed 2019-08-07 | |||||
| 2018-03-31 | $10.00M 10-Q · filed 2019-05-08 | $10.05M derived: sum of 2 quarters · filed 2019-05-08 | $12.43M derived: sum of 3 quarters · filed 2019-05-08 | $18.14M derived: sum of 4 quarters · filed 2019-05-08 | |||||
| 2017-12-31 | $46.17K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $2.43M derived: sum of 2 quarters · filed 2019-03-06 | $8.14M derived: sum of 3 quarters · filed 2019-03-06 | $11.23M 10-K · filed 2019-03-06 | |||||
| 2017-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $8.09M derived: sum of 2 quarters · filed 2018-11-07 | $11.18M 10-Q · filed 2018-11-07 | $11.75M derived: sum of 4 quarters · filed 2019-03-06 | |||||
| 2017-06-30 | $5.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $8.80M 10-Q · filed 2018-08-07 | $9.37M derived: sum of 3 quarters · filed 2019-03-06 | ||||||
| 2017-03-31 | $3.09M 10-Q · filed 2018-05-07 | $3.66M derived: sum of 2 quarters · filed 2019-03-06 | |||||||
| 2016-12-31 | $571.62K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $605.87K 10-K · filed 2019-03-06 | |||||||
| 2016-09-30 | $34.25K 10-Q · filed 2017-11-08 | ||||||||
| 2015-12-31 | $32.72M 10-K · filed 2018-03-12 | ||||||||
| 2013-12-31 | $12.54M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $48.48M derived: sum of 2 quarters · filed 2014-03-31 | $48.48M derived: sum of 3 quarters · filed 2014-03-31 | $48.48M 10-K · filed 2014-03-31 | |||||
| 2013-09-30 | $35.94M derived: 10-K 12 month − 3 quarters · filed 2014-03-31 | $35.94M derived: sum of 2 quarters · filed 2014-03-31 | $35.94M 10-Q · filed 2013-11-13 | $35.94M derived: sum of 4 quarters · filed 2014-03-31 | |||||
| 2013-06-30 | $0.00 derived: 10-Q 21 month − 10-Q 18 month · filed 2013-07-09 | $0.00 derived: sum of 2 quarters · filed 2013-07-09 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | -$40.50K derived: sum of 4 quarters · filed 2014-03-31 | $70.74K 10-Q · filed 2013-07-09 | ||||
| 2013-03-31 | $0.00 derived: 10-Q 18 month − 10-K 15 month · filed 2013-04-24 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | -$40.50K derived: sum of 3 quarters · filed 2014-03-31 | $0.00 derived: sum of 4 quarters · filed 2014-03-31 | $70.74K 10-Q · filed 2013-04-24 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$40.50K derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $40.50K 10-K · filed 2013-02-26 | $70.74K 10-K · filed 2013-02-26 | |||
| 2012-09-30 | -$40.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | $40.50K 10-Q · filed 2012-10-26 | $70.74K 10-Q · filed 2012-10-26 | ||||
| 2012-06-30 | $40.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-18 | $40.50K 10-Q · filed 2013-07-09 | $70.74K 10-Q · filed 2012-07-18 | ||||||
| 2012-03-31 | $30.24K 10-Q · filed 2012-05-14 | ||||||||
| 2011-12-31 | $30.24K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $30.24K 10-K · filed 2013-02-26 | |||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |